A short film that premiered earlier this month tracks the journeys of three people who discovered a renewed commitment to ...

A phase 2 study reveals high efficacy and manageable safety of venetoclax plus obinutuzumab for untreated CLL/SLL in Japanese ...

The term leukemia, colloquially known as blood cancer, is already familiar to most people. No wonder—in Germany, around ...

Record-setting presence at ASH reflects widespread recognition of clonoSEQ as a standard-of-care tool for personalizing ...

Investigators from Hackensack Meridian John Theurer Cancer Center (JTCC)—a leading research partner of the NCI-designated ...

President Donald Trump’s administration announced that Medicare will pay reduced prices for 15 prescription drugs, including ...

Changes in the eyes of leukemia patients can predict treatment response and improvement, according to a study from LV Prasad ...

Nick Hogan hinted at a wrestling career months after his father Hulk Hogan’s death, saying the sport “makes me feel so much ...

Advances in CAR T-cell therapy and bispecific antibodies have expanded treatment options, though access challenges remain. Medicaid expansion has enhanced cancer care in Louisiana, boosting access to ...

Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of ...

(Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to a New Drug Application ...